The importance of understanding the genetics of female carriers, the prevalence of clinical symptoms and how they’re caused, and the services available for symptomatic and non-symptomatic carriers.
February 2, 2024 by Lizzie Cox
February 2, 2024 by Lizzie Cox
Action Duchenne
5th Floor, Mariner House
62 Prince Street
Bristol
BS1 4QD
07535 498 506
info@actionduchenne.org
